Sahm Adrangi is the chief investment officer at Kerrisdale Capital Management LLC. He is also the founder of the firm. He has been a keen participant in the development of the firm since its establishment in 2009. Before founding his firm, he was an analyst who dealt with investments at Longacre Fund Management, LLC. He has also worked at Chanin Capital Partners in the bankruptcy restructuring department. He helped advice creditors with out-of-court settlements. He represented a variety of distressed and bankrupt companies facing foreclosure. Mr. Adrangi also worked for Deutsche Bank where his duties included helping structure high yield bonds. Visit The Hedgefund Journal to know more about Sahm Adrangi.
Sahm Adrangi has an Ivy League Education. He has a Bachelor of Arts degree after graduating from Yale University where he majored in Economics. He was recently caught in a financial battle on wall street when his firm issued a report showing dissatisfaction with Eastman Kodak Company. On the 7TH of February this year, Kerrisdale Capital published a statement explaining its short position in the company’s stake. These reports come on the verge of Eastman Kodak Company announcing a partnership to launch a block chain-enabled image licensing platform and photo-centric cryptocurrency. The announcement skyrocketed its stock price to 187%. These shares have risen on the shoulders of unjustified hype. Eastman Kodak is commercial printing and imaging company. View Sahm Adrangi at hvst.com.
Sahm Adrangi says that the announcements are just a pathetic attempt to cover up the fact that Kodak has poor fundamentals and an unsustainable capital structure. Sahm Adrangi further adds that KODAKOne and KODAKCoin are typically problematic and will not produce the required returns to its shareholders. The developers of these soft wares have highly questionable backgrounds. Kerrisdale Capital has a short position in Eastman Kodak Company and stands to profit when its stock plummets. Sahm Adrangi says that Kodak’s sham of an announcement will not save the company from falling in the stock market and probably an impending SEC Investigation.